Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Novavax | 303 | 2021 | |||||||||
Outset Medical | 100 | 2023q3 | |||||||||
Affimed | 596 | 2021 | |||||||||
Alector | 501 | 2023q2 | |||||||||
ContextLogic | 133 | 2023q3 | |||||||||
Adaptive Biotechnologies | 621 | 2023q3 | |||||||||
RemeGen Co. | 1,155 | 2022 | |||||||||
FuelCell Energy | 515 | 2024q1 | |||||||||
Eurasia Mining | 53 | 2021 | |||||||||
Sangamo Therapeutics | 91 | 2023q3 | |||||||||
Greenlane Holdings | 2 | 2023q2 | |||||||||
Sunrun | 2,492 | 2023 | |||||||||
Apartment Investment and... | 1,165 | 2023q3 | |||||||||
Fidelity National Informa... | 41,743 | 2022 | |||||||||
Blend Labs | 742 | 2023q3 | |||||||||
UroGen Pharma | 477 | 2023q2 | |||||||||
Aytu BioPharma | 10 | 2022 | |||||||||
MicroStrategy | 6,194 | 2023q3 | |||||||||
Alnylam Pharmaceuticals | 18,186 | 2022 | |||||||||
Axsome Therapeutics | 2,954 | 2023q3 |